Despite early success, however, Novo Nordisk has fallen behind in the GLP-1RA race, overtaken by Eli Lilly and its GLP-1RA ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

The Danish multinational said that Sogroya improved the yearly growth rate in pre-pubertal children born small for ...

Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we ...

Novo Nordisk A/S announced earlier today that Lars Rebien Sørensen, Chair of the Novo Nordisk Foundation, will join its board of directors, ...

6 May 2025 – Novo Nordisk today announced that new data spanning the company’s industry-leading portfolio across metabolic and cardiovascular health will be presented at the upcoming 32 nd ...

Discover more exclusive insights and access ... ongoing efforts by Novo Nordisk to navigate regulatory, competitive, and safety challenges in the pharmaceutical industry. This article was ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO ...

Novonesis, a world-leading biosolutions company, co-hosted its 'Unlocking Value for a Sustainable Future' Partnering Day 2025 ...